Valsartan Recall: FDA Issues Warning to API Manufacturer The FDA has issued a warning letter to the manufacturer of the active pharmaceutical ingredient (API) found in valsartan that is the subject of the agency
Currently showing
Ryan Marotta, CPhT, Assistant Editor
Allison Gilchrist, Associate Editor
Allison Gilchrist, Associate Editor
Meghan Ross, Associate Editor
Louis Fox, PharmD Candidate, and Jeff Prescott, PharmD, RPh